These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease. Schrier RW. J Am Soc Nephrol; 2009 Sep; 20(9):1888-93. PubMed ID: 19696226 [Abstract] [Full Text] [Related]
13. The effect of amlodipine and the combination of amlodipine and enalapril on the renin-angiotensin-aldosterone system in the dog. Atkins CE, Rausch WP, Gardner SY, Defrancesco TC, Keene BW, Levine JF. J Vet Pharmacol Ther; 2007 Oct; 30(5):394-400. PubMed ID: 17803730 [Abstract] [Full Text] [Related]
14. Design and baseline characteristics of participants in the study of antihypertensive therapy in children and adolescents with autosomal dominant polycystic kidney disease (ADPKD). Cadnapaphornchai MA, Fick-Brosnahan GM, Duley I, Johnson AM, Strain JD, DeGroff CG, Schrier RW. Contemp Clin Trials; 2005 Apr; 26(2):211-22. PubMed ID: 15837441 [Abstract] [Full Text] [Related]
15. Systemic and renal hemodynamic changes after two-month treatment with enalapril in patients with essential hypertension. Valvo E, Gammaro L, Bedogna V, Tonon M, Giorgetti P, Pica B, Antonini P, Tessitore N, Oldrizzi L, Rugiu C. Int J Clin Pharmacol Ther Toxicol; 1987 Dec; 25(12):656-9. PubMed ID: 2830196 [Abstract] [Full Text] [Related]